1-3 of 3
Jan-Inge Henter, MD
Close
Sort by
Journal Articles

Co-Expression of CD56 and Production of Transforming Growth Factor Beta By Foxp3 Regulatory T Cells from Langerhans Cell Histiocytosis Lesions

Jenee Mitchell, BSc, Egle Kvedaraite, Tatiana von Bahr Greenwood, Jan-Inge Henter, MD PhD, Daniel G Pellicci, Stuart P Berzins, George Kannourakis, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3702.
https://doi.org/10.1182/blood-2018-99-114268
Published: 2018
Journal Articles

Proteasome Inhibitor Bortezomib Disrupts Tumor Necrosis Factor-Related Apoptosis-Inducing ligand (TRAIL) Expression and Natural Killer (NK) Cell Killing of TRAIL Receptor-Positive Multiple Myeloma Cells

Xiaoli Feng, M.D., Jie Yan, MD., Yibiao Wang, MD., Juleen R. Zierath, Ph.D, Magnus Nordenskjöld, MD., Ph.D, Jan-Inge Henter, MD, PhD, Bengt Fadeel, MD, PhD, Chengyun Zheng, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 5021.
https://doi.org/10.1182/blood.V116.21.5021.5021
Published: 2010
Journal Articles

Identification of a MEF Gene Mutation in a Familial Hemophagocytic Lymphohistiocytosis Patient That Decreases MEF Transcriptional Activity.

H. Daniel Lacorazza, PhD, Serena Lopiccolo, MD, Eric Rubenstein, MD, Yan Liu, PhD, Juliana Nunes, B.Sc, Henrik Hasle, MD, Bengt Fadeel, MD, Kim Ericson, MDPhD, Jan-Inge Henter, MD, Stephen D. Nimer, MD
Journal: Blood
Blood (2005) 106 (11): 3013.
https://doi.org/10.1182/blood.V106.11.3013.3013
Published: 2005